BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33571582)

  • 21. Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation.
    Li L; Bao J; Wang H; Lei JH; Peng C; Zeng J; Hao W; Zhang X; Xu X; Yu C; Deng CX; Chen Q
    Theranostics; 2021; 11(4):1672-1689. PubMed ID: 33408774
    [No Abstract]   [Full Text] [Related]  

  • 22. Silencing transcription factor FOXM1 represses proliferation, migration, and invasion while inducing apoptosis of liver cancer stem cells by regulating the expression of ALDH2.
    Chen L; Wu M; Ji C; Yuan M; Liu C; Yin Q
    IUBMB Life; 2020 Feb; 72(2):285-295. PubMed ID: 31580537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysophosphatidic acid decreased macrophage foam cell migration correlated with downregulation of fucosyltransferase 8 via HNF1α.
    Chen L; Zhang J; Yang X; Liu Y; Deng X; Yu C
    Atherosclerosis; 2019 Nov; 290():19-30. PubMed ID: 31557675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer.
    Yu Y; Liu L; Ma R; Gong H; Xu P; Wang C
    Tumour Biol; 2016 Oct; 37(10):14249-14257. PubMed ID: 27571739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
    Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
    Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revisiting the substrate specificity of mammalian α1,6-fucosyltransferase reveals that it catalyzes core fucosylation of
    Yang Q; Zhang R; Cai H; Wang LX
    J Biol Chem; 2017 Sep; 292(36):14796-14803. PubMed ID: 28729420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fucosyltransferase 8 deficiency suppresses breast cancer cell migration by interference of the FAK/integrin pathway.
    Liu D; Gao Z; Yue L
    Cancer Biomark; 2019; 25(4):303-311. PubMed ID: 31306109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis.
    Haque I; Mehta S; Majumder M; Dhar K; De A; McGregor D; Van Veldhuizen PJ; Banerjee SK; Banerjee S
    Mol Cancer; 2011 Jan; 10():8. PubMed ID: 21232118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting anticancer drug delivery to pancreatic cancer cells using a fucose-bound nanoparticle approach.
    Yoshida M; Takimoto R; Murase K; Sato Y; Hirakawa M; Tamura F; Sato T; Iyama S; Osuga T; Miyanishi K; Takada K; Hayashi T; Kobune M; Kato J
    PLoS One; 2012; 7(7):e39545. PubMed ID: 22808043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HnRNPK/miR-223/FBXW7 feedback cascade promotes pancreatic cancer cell growth and invasion.
    He D; Huang C; Zhou Q; Liu D; Xiong L; Xiang H; Ma G; Zhang Z
    Oncotarget; 2017 Mar; 8(12):20165-20178. PubMed ID: 28423622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells.
    Wen Y; Hou Y; Yi X; Sun S; Guo J; He X; Li T; Cai J; Wang Z
    Theranostics; 2021; 11(4):1795-1813. PubMed ID: 33408782
    [No Abstract]   [Full Text] [Related]  

  • 34. m
    Tang B; Yang Y; Kang M; Wang Y; Wang Y; Bi Y; He S; Shimamoto F
    Mol Cancer; 2020 Jan; 19(1):3. PubMed ID: 31906946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis.
    Guo X; Zhou Q; Su D; Luo Y; Fu Z; Huang L; Li Z; Jiang D; Kong Y; Li Z; Chen R; Chen C
    Mol Cancer; 2020 May; 19(1):83. PubMed ID: 32375768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA Linc00337 functions as an E2F1 co-activator and promotes cell proliferation in pancreatic ductal adenocarcinoma.
    Wang H; Yu S; Peng H; Shu Y; Zhang W; Zhu Q; Wu Y; Xu Y; Yan J; Xiang H
    J Exp Clin Cancer Res; 2020 Oct; 39(1):216. PubMed ID: 33054826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isoalantolactone inhibits pancreatic cancer proliferation by regulation of PI3K and Wnt signal pathway.
    Zhang C; Huang L; Xiong J; Xie L; Ying S; Jia Y; Yao Y; Song X; Zeng Z; Yuan J
    PLoS One; 2021; 16(3):e0247752. PubMed ID: 33661942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells.
    Barkeer S; Chugh S; Karmakar S; Kaushik G; Rauth S; Rachagani S; Batra SK; Ponnusamy MP
    BMC Cancer; 2018 Nov; 18(1):1157. PubMed ID: 30466404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.
    Palagani V; El Khatib M; Kossatz U; Bozko P; Müller MR; Manns MP; Krech T; Malek NP; Plentz RR
    PLoS One; 2012; 7(10):e46514. PubMed ID: 23094026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of microRNAs on fucosyltransferase 8 (FUT8) expression in hepatocarcinoma cells.
    Bernardi C; Soffientini U; Piacente F; Tonetti MG
    PLoS One; 2013; 8(10):e76540. PubMed ID: 24130780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.